World J Diabetes 15(5):818822 Ferreira JP, Sharma A, Butler J, Packer M, Zannad F, Vasques-Nvoa F et al (2023) Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure
Besides promoting weight loss and helping avoid overeating, GLP-1 medications may also offer the following benefits: Improves cardiovascular health: Several GLP-1 agonists may be effective in reducing the risk of cardiovascular disease in people with type 2 diabetes
They improve insulin resistance, reduce systemic inflammation, promote weight loss, and offer cardiovascular and liver benefits
Source-known needlesticks (your own used needle) carry minimal infection risk but still warrant evaluation
Lipo-C vs Lipo-B, MIC & GLP-1 Medications Lipo-B vs Lipo-C: both are lipotropic shots